Table 2. Characteristics of relapse VL patients (N = 621) who did or did not have a record of previous treatment for primary VL.
Relapse VL patients who had a record of treatment for primary VL (N = 166) | Relapse VL patients who did not have a record of treatment for primary VL (N = 455) | P-value* | ||
Age group | <5 years | 18.7% | 20.9% | 0.8 |
5–19 years | 47.6% | 46.4% | ||
>19 years | 33.7% | 32.8% | ||
Sex | Male | 59.6% | 57.1% | 0.6 |
Treatment centre | Lankien | 74.1% | 51.9% | <0.001 |
Other | 25.9% | 48.1% | ||
Mean BMI (patients >19 years) (kg/m2) | (n = 51) 15.24 | (n = 108) 16.14 | 0.01 | |
Mean BMI-for-age Z-score (patients 5–19 years) | (n = 65) −3.34 | (n = 149) −3.05 | 0.3 | |
Mean WFH Z-score (patients <5 years) | (n = 31) −2.21 | (n = 86) −2.53 | 0.4 | |
Malnourished (Z-score<−3 or BMI<14kg/m2) | 41.6% | 34.9% | 0.2 | |
Missing height or weight data | 11.5% | 24.6% | <0.001 | |
Mean hemoglobin (g/dl) | 8.32 | 8.27 | 0.9 | |
Missing hemoglobin data | 54.2% | 73.9% | <0.001 | |
Mean duration of illness (months) | 1.8 | 2.5 | <0.001 | |
Missing duration of illness data | 5.4% | 5.1% | 0.9 | |
Spleen size (Hackett Grade) | 0 | 9.6% | 11.2% | 0.003 |
1 | 7.2% | 19.1% | ||
2 | 35.5% | 34.7% | ||
≥3 | 42.2% | 30.6% | ||
Missing | 5.4% | 4.4% | ||
Walking status | Unassisted | 31.9% | 34.5% | 1.0 |
With a stick | 40.4% | 38.7% | ||
Assisted/Stretcher | 10.2% | 9.9% | ||
Missing | 17.5% | 16.9% | ||
Drug used for VL relapse | SSG | 19.3% | 28.6% | 0.1 |
SSG/PM | 72.3% | 65.5% | ||
Other/CAPST | 7.2% | 5.1% | ||
Missing | 0.9% | 1.2% | ||
Treatment outcome | Discharged | 88.6% | 87.7% | 0.7 |
Died | 6.0% | 5.3% | ||
Defaulted | 5.4% | 7.0% |
*Student's t-test for difference between mean values, Chi-squared test for differences in proportions.